Cholesterinestertransferprotein (CETP)-Hemmung mit Obicetrapib zur Senkung des kardiovaskulären Risikos

Die Innere Medizin 2026

View at publisher
Authors: Maximilian Seidel, Sirka Nitschmann, Timm Henning Westhoff
DOI: 10.1007/s00108-025-02035-8
Cited by: 0
References: 3

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular Diseases Cholesterol and Lipid Metabolism

Publication details

Journal / source
Die Innere Medizin
Volume
67
Issue
1
Pages
132–134
Publication date
1 January 2026
Language
DE